Effectiveness and safety of adalimumab in hidradenitis suppurativa: Evidence from Spanish real-world data

被引：0
|
作者：
Martorell, A. [1 ]
Romani, J. [2 ]
Bassas, J. [3 ]
Barboza-Guadagnini, L. [3 ]
Vilarrasa, E. [4 ]
Diaz, R. [5 ]
Pascual, J. C. [6 ]
Martin-Ezquerra, G. [7 ]
Segura, J. M. [8 ]
Arias-Santiago, S. [9 ]
Ruiz-Villaverde, R. [9 ]
Mendieta, M. [10 ]
Garcia-Fernandez, A. [1 ]
机构：
[1] Hosp Manises, Dermatol, Valencia, Spain
[2] Univ Autonoma Barcelona, Hosp Parc Taulf, Dermatol, Sabadell, Spain
[3] Hosp Badalona Germans Trias & Pujol, Dermatol, Barcelona, Spain
[4] Hosp Santa Creu & Sant Pau, Dermatol, Barcelona, Spain
[5] Hosp Univ Infanta Sofia, Dermatol, Madrid, Spain
[6] Hosp Gen Univ Alicante, Dermatol, Alicante, Spain
[7] Hosp del Mar, Dermatol, Barcelona, Spain
[8] Hosp Costa del Sol, Dermatol, Marbella, Spain
[9] Complejo Hosp Granada, Dermatol, Granada, Spain
[10] Hosp Univ Cruces, Dermatol, Bilbao, Spain
来源：
EXPERIMENTAL DERMATOLOGY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
O14-5
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [1] Effectiveness of adalimumab in hidradenitis suppurativa: A real-world study
    Magdalena Moneva-Leniz, Lya
    Garcia-Ruiz, Ramon
    Sanchez Martinez, Eva Maria
    Gegundez Hernandez, Hector
    Melgosa Ramos, Javier
    Garcia Briz, Maria Isabel
    Mateu Puchades, Almudena
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB143 - AB143
  • [2] Real-world experience of adalimumab in the treatment of hidradenitis suppurativa
    Khosravi, Hasan
    Anderson, Alyce M.
    Kettering, Caroline
    Mizes, Alicia
    Patton, Timothy
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (05) : 1406 - 1409
  • [3] Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa
    Garbayo-Salmons, Patricia
    Vilarrasa, Eva
    Bassas-Vila, Julio
    Mora-Fernandez, Veronica
    Fuertes, Irene
    Luque-Luna, Mar
    Fornons-Servent, Rosa
    Martin-Ezquerra, Gemma
    Aguayo-Ortiz, Rafael Sergio
    Ceravalls, Joan
    Mollet, Jordi
    Tomas, Alvaro Gomez
    Masferrer, Emili
    Corral-Magana, Oriol
    Matas-Nadal, Clara
    del Estal, Jorge
    Bailon, Diana Fuertes
    Calvet, Joan
    Romani, Jorge
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [4] Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study
    Mansilla-Polo, Miguel
    Pons-Benavent, Marti
    Fernandez-Crehuet, Pablo
    Vilarrasa, Eva
    Albanell-Fernandez, Cristina
    Morales-Tedone, Enrico
    Rausell-Felix, Francisca
    Alcala-Garcia, Rebeca
    Matellanes-Palacios, Maria
    Martin-Ezquerra, Gemma
    Alfageme, Fernando
    Ciudad-Blanco, Cristina
    Lopez-Villaescusa, Maria Teresa
    Garbayo-Salmons, Patricia
    Martorell, Antonio
    Escutia-Munoz, Begona
    Navarro-Blanco, Fernando
    Martin-Torregrosa, Daniel
    Cuenca-Barrales, Carlos
    Molina-Leyva, Alejandro
    Botella-Estrada, Rafael
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024,
  • [5] Real-world effectiveness and safety of the LAight-therapy in patients with hidradenitis suppurativa
    Strobel, Alexandra
    Schultheis, Michael
    Staubach, Petra
    Grabbe, Stephan
    Mann, Caroline
    Hennig, Katharina
    Szepietowski, Jacek C.
    Matusiak, Lukasz
    Krajewski, Piotr
    von Stebut, Esther
    Garcovich, Simone
    Bayer, Hans
    Heise, Marcus
    Podda, Maurizio
    Kirschner, Uwe
    Nikolakis, Georgios
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024,
  • [6] Real-world drug survival of patients with hidradenitis suppurativa treated with adalimumab
    Saal, Ryan C.
    Alnaif, Sarah
    Edwards, Joshua F.
    Wintringham, Jennifer A.
    Smith, Robert J.
    [J]. JAAD INTERNATIONAL, 2023, 11 : 209 - 210
  • [7] Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: A 52-week analysis of a postmarketing surveillance study in Japan
    Hayashi, Nobukazu
    Hayama, Koremasa
    Takahashi, Kenzo
    Kurokawa, Ichiro
    Okazaki, Masateru
    Kashiwagi, Tomoko
    Iwashita, Eri
    Terui, Tadashi
    [J]. JOURNAL OF DERMATOLOGY, 2023, 50 (08): : 1034 - 1044
  • [8] Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness
    Corrigan-Curay, Jacqueline
    Sacks, Leonard
    Woodcock, Janet
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (09): : 867 - 868
  • [9] Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan
    Hayashi, Nobukazu
    Hayama, Koremasa
    Takahashi, Kenzo
    Kurokawa, Ichiro
    Okazaki, Masateru
    Kashiwagi, Tomoko
    Iwashita, Eri
    Terui, Tadashi
    [J]. JOURNAL OF DERMATOLOGY, 2022, 49 (04): : 411 - 421
  • [10] Cost-savings of adalimumab in hidradenitis suppurativa: a retrospective analysis of a real-world cohort
    Argyropoulou, M.
    Kanni, T.
    Kyprianou, M.
    Melachroinopoulos, N.
    Giamarellos-Bourboulis, E. J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (05) : 1161 - 1168
12345